Lunai Bioworks Inc. (LNAI)
NASDAQ: LNAI · Real-Time Price · USD
0.3246
+0.0047 (1.47%)
At close: May 4, 2026, 4:00 PM EDT
0.2975
-0.0271 (-8.35%)
After-hours: May 4, 2026, 7:59 PM EDT
Lunai Bioworks Market Cap
Lunai Bioworks has a market cap or net worth of $11.77 million as of May 4, 2026. Its market cap has decreased by -81.17% in one year.
Market Cap
11.77M
Enterprise Value
14.04M
1-Year Change
-81.17%
Ranking
Category
Stock Price
$0.32
Market Cap Chart
Since April 3, 2018, Lunai Bioworks's market cap has decreased from $198.90M to $11.77M, a decrease of -94.08%. That is a compound annual growth rate of -29.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 1, 2026 | 11.60M | -43.83% |
| Dec 31, 2025 | 20.66M | -84.42% |
| Dec 31, 2024 | 132.61M | -37.28% |
| Dec 29, 2023 | 211.43M | 287.68% |
| Dec 30, 2022 | 54.54M | -85.67% |
| Dec 31, 2021 | 380.68M | 176.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Apr 3, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioLineRx | 12.42M |
| BioCardia | 12.36M |
| GT Biopharma | 12.07M |
| Kairos Pharma | 12.05M |
| Cellectar Biosciences | 12.00M |
| CytoMed Therapeutics | 11.80M |
| Chemomab Therapeutics | 11.66M |
| Quoin Pharmaceuticals | 11.47M |